Skip to content

Clinical trials

Phase 3 Panuveitis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Panuveitis Phase: Phase 3 Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20041
20073
20091
20104
20111
20122
20141
20152
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated6
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Lux Biosciences, Inc.3
XOMA (US) LLC3
Clearside Biomedical, Inc.2
Sirion Therapeutics, Inc.2
EyePoint Pharmaceuticals, Inc.1
Novartis1
University Hospital Tuebingen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Panuveitis18
Uveitis15
Uveitis, Posterior15
Uveitis, Intermediate14
Uveitis, Anterior4
Behcet Syndrome2
Cardiovascular Diseases1
Dermatitis1
Inflammation1
Myocardial Infarction1

Trials

Showing 26 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.